Radient Technologies Inc.'s Board of Directors is conducting a strategic review of the company’s operations, including management changes.

Willow Biosciences Inc. says it has successfully developed a scalable process for producing cannabigerol (CBG) with greater than 99 percent purity, no detectable THC and demonstrated production at 500-litre scale.

Through a proprietary process, Open Book Extracts is producing commercial quantities of bulk CBN at greater than 99 percent purity.

Demetrix Inc., a biotechnology company that makes safe and effective cannabinoids, has commenced 15,000-liter demo-scale fermentation production of the rare cannabinoid cannabigerol (CBG).

Folium Biosciences has finished construction on a 110,000-sq.-ft. cannabinoid extraction and purification facility in Pueblo West, CO.

Mile High Labs has closed a Series B equity financing round from American entrepreneur John Paul DeJoria. The financing will be used to pay off existing debt and accelerate the development of its manufacturing and formulations platform.

The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous sclerosis complex, a genetic disorder characterized by growth of numerous noncancerous tumors.